Lymphoma
Lymphoma
Epidemiology
Lymphoma ranks among the most significant hematological malignancies worldwide, with an estimated global incidence of approximately 605,000 cases reported annually in 2020.¹ In the United States, the annual incidence of lymphoma is estimated to be about 89,010 new cases, with approximately 21,080 deaths each year, highlighting the substantial public health impact of this disease.² Despite advances in therapies, lymphoma remains a significant contributor to cancer-related mortality across regions.³ The occurrence of spontaneous remission (SR) in lymphoma is remarkably rare, with documented rates often below 2%, and the true incidence may be further obscured due to underreporting and lack of recognition of remissions that are less pronounced.⁴
Clinical Characteristics:
A total of 205 well-documented cases of spontaneous remission (SR) in lymphoma have been reported between 1956 and 2025. The ages of affected individuals ranged from 2 to 94 years (mean ≈ 52.2 years), with a near-equal male-to-female ratio of approximately 1.1:1 and a peak incidence observed in the 60–80-year age group. Overall, SR was documented across a wide age spectrum but occurred more frequently in older adults, with remission most often noted in generalized or disseminated disease rather than localized lesions, involving both nodal and extranodal sites. See table 1 below for further information.
Histological Characteristics:
Patients who experienced spontaneous remission of lymphoma typically presented with lymphadenopathy or extranodal masses confirmed histologically as malignant lymphoid proliferations. Most cases involved advanced or systemic disease, with the lymph nodes, spleen, and bone marrow as the predominant primary sites, and occasional involvement of the skin, gastrointestinal tract, central nervous system, or thyroid. Remission was verified by follow-up biopsies or imaging demonstrating regression or disappearance of lymphoma cells. Nearly all SR cases showed durable clinical stability or long-term remission, far exceeding the expected prognosis for untreated lymphoma.
Proposed Contributing Mechanisms:
Several mechanisms have been proposed to explain spontaneous remission in lymphoma. The most common involve immune activation following bacterial or viral infections, febrile illnesses, or other inflammatory events. Additional contributing factors include biopsy-related immune stimulation, recovery after withdrawal of immunosuppressive or cytotoxic therapy such as methotrexate or cyclosporine, and immune restoration following discontinuation of antiretroviral or other immunomodulatory treatments. A minority of reports suggest cellular processes such as apoptosis, cytokine-mediated tumor inhibition, or radiation-related immune enhancement as potential contributors.
Site and Extent of Remission:
In most reported cases of spontaneous remission in lymphoma, regression occurred within nodal sites, including cervical, axillary, mediastinal, and abdominal lymph nodes. Extranodal remissions were also documented, involving the skin, gastrointestinal tract, central nervous system, thyroid, breast, and other organs. In many patients, remission extended across multiple regions, reflecting systemic disease resolution rather than localized tumor regression. The duration of remission ranged from a few weeks to more than 20 years, with a considerable number of patients maintaining prolonged clinical and radiologic remission in the absence of active treatment.
Table 1: Leukemia SR Cases and Clinical Characteristics
Author–year | Age/sex | Primary site | Remission site | Proposed mechanisms | Follow-up |
|---|---|---|---|---|---|
68/M | Lymph nodes and liver | Lymph nodes and liver | Humoral factors | 4 years | |
2.5/M | Neck | Neck lymph nodes | Not reported | Not reported | |
43/M | Mediastinal and axillary nodes | Paratracheal nodes and skin | Infection-related immune response | Not reported | |
56/F | Submandibular and cervical nodes | Axillary node | Infection-related immune response | Not reported | |
83/F | Scalp | Scalp | Not reported | 15 months | |
9/M | Jaw | Jaw | Not reported | Not reported | |
6/M | Mandible and maxilla | Mandible and maxilla | Not reported | 14 months | |
36/F | Breast and shoulder | Breast and shoulder | Not reported | Not reported | |
4/F | Maxilla and orbit | Maxilla and orbit | Infection-related immune response | 2 years | |
Not reported | Blood | Blood, bone marrow | Immunological response | Not reported | |
9/M | Maxilla, orbit, intracranial | Maxilla and orbit | Immunological response | 2 months | |
11/M | Maxilla | Maxilla | Immunological response | 7 years | |
6/F | Maxilla and abdomen | Not reported | Not reported | 3 months | |
7/F | Maxilla and abdomen | Not reported | Not reported | 3 months | |
15/M | Maxilla and orbit | Maxilla and orbit | Immunological response | 3 years | |
9/M | Maxilla, orbit, intracranial | Maxilla and orbit | Immunological response | 10 months | |
9/M | Maxilla | Maxilla | Immunological response | Not reported | |
6/M | Maxilla and abdomen | Maxilla and abdomen | Immunological response | 2 years | |
16/M | Inguinal node | Inguinal and mediastinal nodes | Immunologic factors | 5 years | |
12/F | Face, iliac fossa, ovary | Face and ovaries | Not reported | 3 months | |
8/M | Orbit | Orbit | Infection-related immune response | 4 months | |
Not reported | Blood | Blood | Antitumor immunity | Not reported | |
Not reported | Not reported | Not reported | Not reported | several years | |
42/M | Lymph nodes | Lymph nodes | Not reported | 5 years | |
43/F | Nodes | Peripheral and thoracic nodes | Not reported | 32 months | |
68/F | Nodes | Peripheral and abdominal nodes | Not reported | 2 years | |
42/M | Nodes | Peripheral and abdominal nodes | Not reported | 5 years | |
61/M | Intracerebral | Intracerebral | Steroid effect | 5 months | |
60/F | Intracerebral | Left temporal lobe | Steroid effect | 4 years | |
69/F | Intracerebral | Intracerebral | Not reported | 3 months | |
69/F | Frontal lobe | Frontal lobe | Not reported | 4 months | |
Not reported | Not reported | Lymph nodes | Viral infection, interferon effect | 5–10 years | |
12/F | Gastrointestinal tract, reproductive organs, CNS | Bone marrow | Infection-related immune response | 11 months | |
69/F | Mediastinum | Mediastinum | Hormonal factors | 27 days | |
54/F | Tongue base | Cervical node | Infection-related immune response | 4 years | |
56/F | CNS | CNS | Steroid-induced cytotoxicity | Not reported | |
84/M | GI (stomach, antrum) | Stomach | Immunomodulatory effect | 10 months | |
73/M | GI (stomach, antrum) | Gastric antrum | Immunomodulatory effect | 16 months | |
12/M | Tonsil and cervical node | Tonsil and cervical node | Host cytotoxic response | 3 years | |
63/F | CNS | Frontal and parietal lobes | Immune response | Not reported | |
40/F | Stomach (pyloric antrum) | Stomach | Not reported | 69 months | |
73/M | Stomach (posterior antrum) | Stomach | Not reported | 44 months | |
56/F | Axilla and groin nodes | Epitrochlear and inguinal nodes | Infection-related immune response | >20 years | |
Not reported | Not reported | Not reported | Immune response, infection | Not reported | |
21/M | Brain | Brain | Immunosuppression withdrawal | Not reported | |
75/F | Skin | Cutaneous lesions | Not reported | 10 months | |
43/F | Skin | Cutaneous nodules | Not reported | 6 months | |
43/M | Pharynx | Cervical nodes | Infection-related immune response | Infection-related immune response | |
30/M | Skin and chest wall | Forehead and chest wall tumors | Immune response, interferon activity | Not reported | |
34/M | Central nervous system | Thalamus and midbrain lesion | Tumor necrosis | Not reported | |
67/M | Lymph nodes | Bone marrow and lymph nodes | Viral infection, immune response | 16 months | |
27/F | Skin | Skin | Infection-related immune response | Not reported | |
62/F | Intravascular (skin and bone marrow) | Skin and bone marrow | Not reported | Not reported | |
35/M | Oral cavity, lung, bowel, spleen | Oral cavity, lung, bowel, spleen | Not reported | 9 years | |
79/F | Lymph nodes | Lymph nodes (inguinal, para-aortic) | Infection-induced immune response | 18 months | |
76/M | Rectum | Rectum | Not reported | 19 months | |
52/F | Spleen | Spleen | Not reported | 14 months | |
69/F | Cervical lymph nodes | Cervical lymph nodes | Methotrexate withdrawal | 14 months | |
61/F | Lumbar spine | Lumbar spine | Not reported | 8 months | |
47/M | Mediastinum (lymph nodes) | Mediastinum, and axillary lymph nodes | Not reported | 15 months | |
78/F | Gingiva (left maxillary) | Gingiva (left maxillary) | Immune response | 36 months | |
61/M | CNS (corpus callosum, tectum) | Corpus callosum | Not reported | 3.5 years | |
70/M | Stomach | Stomach | Withdrawal of cyclosporine treatment | 10 months | |
70/M | Oral cavity (mandible) | Oral cavity (mandible) | Biopsy-induced apoptosis | 20 months | |
46/F | Breast (right) | Breast (right) | Biopsy-induced immune response | 7 years | |
40/F | Conjunctiva | Conjunctiva and orbit | Biopsy-induced immune activation | 5 weeks | |
45/M | Left axillary lymph nodes | Left axillary, mediastinal, and para-aortic lymph nodes | Not reported | 6 months | |
59/F | Left parotid lymph node | Inguinal lymph nodes | Not reported | 5 years | |
75/M | Posterior cervical lymph nodes (left neck) | Cervical lymph nodes | Not reported | 14 months | |
76/M | Orbital apex | Orbital apex, frontal lobe | Not reported | 2 years | |
64/F | Sinuses | Sinuses | Methotrexate withdrawal | 6 months | |
36/M | Subcutaneous tissue (left thigh) | Subcutaneous tissue (left thigh) | Biopsy-induced immune response | 6 months | |
47/M | Cecum | Cecum | Antiretroviral therapy for HIV | 5.5 years | |
72/M | Skin (left forearm) | Skin (left forearm) | Not reported | 1 year | |
32/F | Skin (right cheek) | Skin (right cheek) | Not reported | 2 years | |
70/F | Intraoral mucosa | Hard palate | Post-biopsy immune activation | 38 months | |
48/F | Bone marrow | Abdominal lymph nodes, bone marrow | Methotrexate withdrawal | 12 months | |
45/M | CNS | CNS | Immune response | 18 months | |
72/M | Bilateral conjunctiva | Bilateral conjunctiva | Not reported | 24 months | |
35/F | Left axilla | Left axilla | Not reported | 2 years | |
54/F | Lungs | Lungs, liver, spleen | Methotrexate withdrawal | 3 months | |
35/M | Oral cavity | Oral cavity | HAART-induced immune restoration | 1 month | |
89/M | Inguinal lymph node | Inguinal and cervical lymph nodes | Immune modulation | 31 months | |
26/M | Submandibular gland | Lymph nodes | Immune response | 6 months | |
48/M | Skin (anterior chest wall and back) | Skin (anterior chest wall and back) | Not reported | 24 months | |
56/M | Oral cavity | Oral cavity | Biopsy-induced immune activation | 4 years | |
2/M | Right mastoid | Right mastoid | Not reported | 24 months | |
65/F | Skin (eyelid) | Submandibular lymph node | EBV-related immune activation | 5 years | |
64/M | Skin (right leg) | Skin (right leg) | Reduction of immunosuppression | 9 months | |
Elderly/M | Cervical lymph nodes | Cervical, axillary, and tonsillar regions | Trauma-related immune activation | 4 weeks | |
38/M | Ileum mucosa | Ileum mucosa | Not reported | 24 months | |
14/M | Lymph nodes | Lymph nodes | Not reported | 4 years | |
69/F | Breast | Breast | Biopsy-induced immune response | Not reported | |
59/F | Duodenum | Duodenum | Not reported | 3-4 months | |
76/F | Duodenum | Duodenum | Not reported | Not reported | |
76/M | Duodenum | Duodenum | Not reported | Not reported | |
72/M | Duodenum | Duodenum | Not reported | 7 months | |
67/F | Duodenum | Duodenum | Not reported | 7 months | |
72/F | Duodenum | Duodenum | Not reported | Not reported | |
48/F | Skin (left forearm) | Skin (left forearm) | Biopsy-induced apoptosis | 10 months | |
54/F | Intra-abdominal lymph nodes | Liver, spleen, and intra-abdominal lymph nodes | Withdrawal of adalimumab | 3 months | |
12/F | Cervical lymph nodes | Cervical lymph nodes, skin | Not reported | 4 weeks | |
80/M | Eye | Intraocular tissues | Immune response, CD8 T cells | 8 months | |
67/F | Maxillary sinus | Maxillary sinus | Infection-induced immunity | 1 year | |
86/F | Lymph nodes | Lymph nodes | Immune response | 8 months | |
8/F | Skin | Left areola | Apoptosis | 6 years | |
24/F | Central nervous system and lungs | Brain and lung lesions | Improved immunity | 1 year | |
10/F | Lymph nodes | Lymph nodes, bone marrow, liver | Immune response | 14 months | |
94/F | Lymph nodes | Lymph nodes | Immune recovery | 10 months | |
63/M | Lymph nodes | Lymph nodes | Not reported | 12 months | |
68/F | Left breast | Left breast | Not reported | 14 months | |
57/M | Stomach | Gastric | Not reported | 2 years | |
57/F | Lung | Lung | Apoptosis of lymphocytes | 3 months | |
87/M | Gingiva | Gingiva | Biopsy-induced immune stimulation | 2.5 years | |
55/M | Kidney | Kidney | Immune reconstitution | 10 months | |
38/M | Lymph nodes | Axillary lymph nodes | Biopsy-induced trauma | Not reported | |
80/M | Oral cavity | Gingiva | Immune response | 5 months | |
61/F | Blood | Bone marrow | Apoptosis | 6 years | |
60/F | Lymph nodes | Supraorbital region | Immune response | 36 months | |
58/F | Blood | Blood and skin | Immune response | 58 months | |
62/M | Skin | Right cheek | Not reported | 12 months | |
66/M | Urinary bladder | Urinary bladder | Recovery from immunosuppression | Not reported | |
83/F | Thyroid | Thyroid | Radiation exposure | 9 years | |
51/F | Thyroid | Thyroid | Radiation exposure | 8 years | |
60/M | Ileocecal region | Ileocecal region | Radiation exposure | Not reported | |
69/F | Thyroid | Thyroid | Radiation exposure | 21 years | |
72/F | Lung | Lung | Biopsy-induced immune activation | 40 months | |
59/M | Lymph nodes | Para-aortic lymph nodes | Biopsy-induced immune response | 12 months | |
20/M | Skin | Left alar base | Not reported | 4 months | |
66/M | Lymph nodes | Lymph nodes and spleen | Not reported | 52 months | |
74/M | CNS | CNS | Immune response | 2 years | |
72/F | Skin | Left arm | Immune response | 21 months | |
46/M | Skin | Lip | Biopsy-induced immune activation | 14 months | |
51/F | Breast | Breast | Not reported | Not reported | |
24/F | Breast | Breast | Not reported | Not reported | |
48/M | Right inguinal lymph node | Lymph nodes | Immune response | 5 years | |
63/M | Right axillary lymph node | Lymph nodes | Immune response | 3 years | |
68/M | Inguinal and cervical lymph nodes | Lymph nodes | Immune response | 5 years | |
44/F | Inguinal and pelvic lymph nodes | Lymph nodes, Bone marrow | Immune response | 1.5 years | |
44/F | Skin | Skin | Drug withdrawal immune restoration | 4 weeks | |
79/M | Skin | Left leg | Immune response | 12 months | |
50/F | Brain | Brain | Viral infection–induced NK cell activation | Not reported | |
66/M | Skin | Left lower leg | Immune response | Not reported | |
79/M | Lung | Lung | MTX withdrawal immune recovery | 1 month | |
66/M | Skin | Skin | Not reported | Few months | |
32/F | Lymph nodes | Lymph nodes | Not reported | 2 years | |
88/F | Lymph nodes | Lymph nodes | Biopsy-induced immune response | 3 months | |
35/M | Small intestine | Small intestine, Lymph nodes | PD-L1/PD-1–mediated apoptosis | 3 months | |
69/M | Bone marrow | Bone marrow, Spleen | Not reported | 6 weeks | |
70/M | Bronchi | Bronchi | Not reported | Not reported | |
47/M | Lymph nodes | Lymph nodes, Bone marrow, Spleen, Stomach | Immune response | 3 months | |
74/M | Liver | Liver, Spleen, Bone | Immune-mediated response | 1.5 months | |
78/M | Skin | Skin | Not reported | 8 months | |
24/F | Breast | Breast | Not reported | Not reported | |
51/F | Breast | Breast | Not reported | 2 months | |
35/M | Retroperitoneum | Retroperitoneum | Biopsy-induced immune response | 6 months | |
76/F | Vagina | Vagina, Lung | Not reported | 1 year | |
57/M | Lymph nodes | Lymph nodes | Vaccine-induced immune activation | 1 month | |
54/F | Cervix | Cervix | Biopsy-induced immune response | Not reported | |
59/M | Cheek | Cheek | T-cell–mediated immunity | 5.5 months | |
65/F | Vitreous | Vitreous | Not reported | 1 week | |
11/F | Lymph nodes | Lymph nodes, Spleen | Infection-related immune activation | Several months | |
84/M | Gingiva | Gingiva | Drug withdrawal effect | Not reported | |
61/M | Sinus | Sinus | Biopsy-induced immune response | Not reported | |
63/F | Breast | Breast, lung, retroperitoneum | Methotrexate withdrawal | 6 months | |
80/M | Eye | Eye | Not reported | 1 year | |
71/F | Eye | Eye | Biopsy-induced immune response | 6 months | |
55/F | Pleura, Pericardium | Pleura, Pericardium | Not reported | Not reported | |
62/M | Skin | Skin | Biopsy-induced immune response | 3 months | |
15/M | Maxillary bone | Maxillary bone | Not reported | 8 months | |
3/M | Lymph nodes | Lymph nodes | Not reported | 3 weeks | |
32/M | Colon | Brain, Colon | Immune reconstitution | 1 year | |
53/F | Skin | Skin | Reactive T-cell infiltration | 9 years | |
27/F | Mediastinum | Mediastinum, Lymph nodes | Feto-maternal microchimerism | 6 months | |
75/F | Mandible | Mandible, Lungs | MTX withdrawal immune recovery | 6 months | |
35/M | Skin | Skin | Immune reconstitution | 3 months | |
Li et al., 2025141 | 72/M | Lung | Lung | Biopsy-induced immune response | 5 months |
79/M | Forehead and anterior scalp | 2 months | |||
83/M | Face, neck, trunk | 6 months | |||
68/M | Axillary and inguinal regions | Spleen and liver | Interferon production | 4 weeks | |
76/F | Lymph nodes | Lymph nodes | Immune reaction | Lymphadenopathies disappeared by April 1980 | |
76/F | Lymph nodes | T lymphocyte subset imbalance | |||
83/F | Scalp | Scalp | Local trauma considered | 8 months | |
42/M | Lymph nodes | Lymph nodes | Host immunity and environmental factors | Asymptomatic at 5 years | |
68/F | Lymph nodes | Lymph nodes | Host immunity | Asymptomatic at 2 years | |
43/F | Lymph nodes | Lymph nodes | Host immunity | 32 months | |
26/F | Face, genital area | Forehead tumor, genital tumor | Progressive fibrosis, inflammatory process | Discharged 2 months after admission | |
36/M | Back | Connective tissue alteration | |||
16/M | Mediastinal mass and cervical lymph nodes | Cervical lymph nodes and mediastinal mass | Surgical exploration and procaine role | ||
61/F | Spleen | Removal of the spleen | 11 years | ||
46/M | Skin | Skin nodules | 2.5 years | ||
48/F | Lymph nodes | Complete remission until Feb 1981 | |||
42/M | Lymph nodes | Complete remission | |||
65/M | Cerebral, right frontal CC | Cerebral lesions | Immune theory | 4 months, asymptomatic | |
82/F | Skin on right leg | Skin lesions | Infiltrate contributed to regression | 4 weeks | |
44/M | Left nasal ala | Left nasal ala | Asymptomatic after 1 year | ||
83/F | Back of right leg | Back of right leg | Immune response against tumor cells | Asymptomatic after 1 year | |
85/M | Prostate | Pelvic lymph nodes | Immunological response post-biopsy | 31 months | |
89/M | Body cavities | Pleural effusion | None reported | 40 months | |
65/F | Skin ulcer | Skin ulcer | Antiviral treatment and reduced immunosuppression | 18 months | |
53/M | Brain (CNS) | Deep white matter of right hemisphere | Infarction and necrosis | Symptom free, remarkable tumor reduction | |
52/M | Lymph nodes and spleen | Lymph nodes | Discontinuation of cyclosporine | 30 months, psoriasis controlled | |
46/M | Lymph nodes, spleen, liver | Left axilla | 4 weeks post-surgery | ||
66/F | Tongue | 7 years, untreated | |||
23/F | Bilateral areolae | Bilateral areolae | Self-limited disease or biopsy-triggered regression | 6 months | |
69/M | Brain | Right deep white matter | Regression and progression of inflammation | 7 days | |
69/F | Lymph nodes and liver | Normal lymphocyte count reached in September 1966 | |||
41/F | Spontaneous remission, normal coagulation studies | ||||
2/F | Spontaneous and quick recovery | ||||
80/F | Lymph nodes | ||||
Spontaneous remission | |||||
Lymphoid stem cell clone development | 18 years |
References
- Anday GJ, Schmitz HL, Limarzi LR. Follicular lymphoma with full remission of leukemic phase. AMA Arch Intern Med. 1956;97(5):631–638. doi:10.1001/archinte.1956.00250230125014
- Diwani M, Gabr M, Essawy M, Elwi A. Malignant Lymphoma in Childhood. Arch Pediatr. 1960;77(10):406–420.
- Tigerightt WD, Crosby WH, Berge TO, Howie DL, Kress S, Dangerfield HG, Bass JW, Frank W. The virus of Venezuelan equine encephalomyelitis as an antineoplastic agent in man. Cancer. 1962;15:628–632. doi:10.1002/1097-0142(196205/06)15:3<628::AID-CNCR2820150326>3.0.CO;2-A
- Kwittken J, Goldberg AF. Follicular Lymphoma of the Skin. Arch Dermatol. 1966;93:177–183.
- Burkitt DP, Kyalwazi SK. Spontaneous remission of African lymphoma. Br J Cancer. 1967;21(1):14–16. doi:10.1038/bjc.1967.2
- Burkitt DP. Clinical Evidence Suggesting the Development of an Immunological Response Against African Lymphoma. In: Burchenal JH, Burkitt D, eds. Treatment of Burkitt’s Tumour. UICC Monograph Series, Vol 8. New York: Springer-Verlag; 1967:197–208.
- David J, Burkitt D. Burkitt’s lymphoma: remissions following seemingly non-specific therapy. Br Med J. 1968;4(5626):288–289. doi:10.1136/bmj.4.5626.288
- Kiely JM, Harrison EG Jr. Long-term remission in Hodgkin’s disease after nitrogen mustard therapy. Cancer. 1970;26(4):800–802. doi:10.1002/1097-0142(197010)26:4<800::AID-CNCR2820260409>3.0.CO;2-T
- Jamra M, Carvalho RP, Dalldorf G. Evolution of an atypical case of Burkitt lymphoma. Lancet. 1970;2(7674):672. doi:10.1016/S0140-6736(70)91449-2
- Bluming AZ, Ziegler JL. Regression of Burkitt’s lymphoma in association with measles infection. Lancet. 1971;2(7715):105–106. doi:10.1016/S0140-6736(71)92086-1
- Ziegler JL. Spontaneous Remission in Burkitt’s Lymphoma. Natl Cancer Inst Monogr. 1976;44:61–65.
- Gattiker HH, Wiltshaw E, Galton DAG. Spontaneous Regression in Non-Hodgkin’s Lymphoma. Cancer. 1980;45(10):2627–2632.
- Krikorian JG, Porightlock CS, Cooney P, Rosenberg SA. Spontaneous regression of non-Hodgkin’s lymphoma: a report of nine cases. Cancer. 1980;46(9):2093–2099. doi:10.1002/1097-0142(19801101)46:9<2093::AID-CNCR2820460931>3.0.CO;2-4
- Weingarten KL, Zimmerman RD, Leeds NE. Spontaneous regression of intracerebral lymphoma. Radiology. 1983;149(3):721–724. doi:10.1148/radiology.149.3.6359262
- Horning SJ, Rosenberg SA. The Natural History of Initially Untreated Low-Grade Non-Hodgkin’s Lymphomas. N Engl J Med. 1984;311(23):1471–1475.
- McClain K, Warkentin P, Kay N. Spontaneous remission of Burkitt's lymphoma associated with herpes zoster infection. Am J Pediatr Hematol Oncol. 1985;7(1):9–14.
- Weaver GR, Cohn JH, Mintzer RA. Transient spontaneous regression of an anterior mediastinal mass. Chest. 1985;87(4):547–548. doi:10.1378/chest.87.4.547
- Grem JL, Hafez GR, Brandenburg JH, Carbone PP. Spontaneous remission in diffuse large cell lymphoma. Cancer. 1986;57(10):2042–2044. doi:10.1002/1097-0142(19860515)57:10<2042::AID-CNCR2820571027>3.0.CO;2-#
- Rubin M, Libman I, Brisson ML, Goldenberg M, Brem S. Spontaneous temporary remission in primary CNS lymphoma. Can J Neurol Sci. 1987;14(2):175–177. doi:10.1017/S0317167100026354
- Strauchen JA, Moran C, Goldsmith M, Greenberg M. Spontaneous regression of gastric lymphoma. Cancer. 1987;60(8):1872–1875. doi:10.1002/1097-0142(19871015)60:8<1872::AID-CNCR2820600833>3.0.CO;2-6
- Poppema S, Postma L, Brinker M, de Jong B. Spontaneous regression of a small non-cleaved cell malignant lymphoma (non-Burkitt’s lymphoblastic lymphoma). Morphologic, immunohistological, and immunoglobulin gene analysis. Cancer. 1988;62(4):791–794. doi:10.1002/1097-0142(19880815)62:4<791::AID-CNCR2820620425>3.0.CO;2-M
- Sugita Y, Shigemori M, Yuge T, Iryo O, Kuramoto S, Nakamura Y, Morimatsu M. Spontaneous regression of primary malignant intracranial lymphoma. Surg Neurol. 1988;30(2):148–152. doi:10.1016/0090-3019(88)90102-4
- Shigematsu A, Iida M, Lien GS, Imamura T, Okada M, Fuchigami T, Fujishima M, Itoh H, Iwashita A. Spontaneous regression of primary malignant lymphoma of the stomach in two nontreated Japanese. J Clin Gastroenterol. 1989;11(5):511–517. doi:10.1097/00004836-198910000-00006
- Wolf JW. Prolonged spontaneous remission of case of malignant lymphoma. Mo Med. 1989;86(5):275–277.
- Drobyski WR, Qazi R. Spontaneous Regression in Non-Hodgkin’s Lymphoma: Clinical and Pathogenetic Considerations. Am J Hematol. 1989;1:138–141.
- Fric M, Hartmann A, Klehr HU, Pfeifer U, Herberhold C. Regression of cerebral post-transplantation lymphoma under cyclosporin A reduction. Klin Wochenschr. 1990;68(23):1189-1194. doi:10.1007/BF01815278
- Aelbrecht M, Geerights ML. Lymphoplasmocytoid immunocytoma. Dermatologica. 1990;180(3):191–192.
- Mayou SC, Anstey A, Norighton AJ, et al. Angiocentric T-cell lymphoma in skin. J R Soc Med. 1991;84(11):683–684.
- Daniels D, Lowdell CP, Glaser MG. The spontaneous regression of lymphoma in AIDS. Clin Oncol (R Coll Radiol). 1992;4(3):196–197. doi:10.1016/S0936-6555(05)81090-8
- Karnad AB, Jaffar A, Lands RH. Spontaneous regression of acquired immune deficiency syndrome-related, high-grade, extranodal non-Hodgkin’s lymphoma. Cancer. 1992;69(7):1856–1857. doi:10.1002/1097-0142(19920401)69:7<1856::AID-CNCR2820690730>3.0.CO;2-Q
- Terriff BA, Harrison P, Holden JK. Apparent spontaneous regression of AIDS-related primary CNS lymphoma mimicking resolving toxoplasmosis. J Acquir Immune Defic Syndr. 1992;5(9):953–954.
- Grigg AP, Gray GR, Shepherd JD. Spontaneous remission of multilobated non-Hodgkin lymphoma. Am J Hematol. 1992;40(3):222–225. doi:10.1002/ajh.2830400312
- Motley RJ, Jasani B, Ford AM, Poynton CH, Calonje-Daly JE, Holt PJ. Regressing atypical histiocytosis, a regressing cutaneous phase of Ki-1-positive anaplastic large cell lymphoma. Cancer. 1992;70(2):476–483. doi:10.1002/1097-0142(19920715)70:2<476::AID-CNCR2820700216>3.0.CO;2-5
- Kiyohara T, Kumakiri M, Kobayashi H, Shimizu T, Ohkawara A, Ohnuki M. A case of intravascular large B-cell lymphoma mimicking erythema nodosum: the importance of multiple skin biopsies. J Cutan Pathol. 2000;27(8):413–418. doi:10.1034/j.1600-0560.2000.027008413.x
- Ranheim EA, Jones C, Zehnder JL, Warnke R, Yuen A. Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature. Am J Surg Pathol. 2000;24(2):296-301. doi:10.1097/00000478-200002000-00017
- Takezako Y, Kanda Y, Arai C, Takezako N, Shirai Y, Hirano N, Togawa A. Spontaneous remission in acute type adult T-cell leukemia/lymphoma. Leuk Lymphoma. 2000;39(1-2):217-222. doi:10.3109/10428190009053558
- Takenaka R, Tomoda J, Sakata T, Ichiba T, Motoi M, Mizuno M, Tsuji T. Mucosa-associated lymphoid tissue lymphoma of the rectum that regressed spontaneously. J Gastroenterol Hepatol. 2000;15(3):331-335. doi:10.1046/j.1440-1746.2000.02086.x
- Phanish MK, Owen A, Parry DH. Spontaneous regression of acquired C1 esterase inhibitor deficiency associated with splenic marginal zone lymphoma presenting with recurrent angio-oedema. J Clin Pathol. 2002;55(10):789–790. doi:10.1136/jcp.55.10.789
- Baird RD, van Zyl-Smit RN, Dilke T, Scott SE, Rassam SM. Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature. Br J Haematol. 2002;118(2):567–568. doi:10.1046/j.1365-2141.2002.03619.x
- Ohgi S, Ehara S, Satoh T, Kato S, Shimosegawa K, Ishida Y. Spontaneous regression of malignant lymphoma of the lumbar spine. Skeletal Radiol. 2002;31(2):99–102. doi:10.1007/s00256-001-0446-z
- Mangel J, Barth D, Berinstein NL, Imrie KR. Spontaneous regression of Hodgkin’s disease: two case reports and a review of the literature. Hematology. 2003;8(3):191–196. doi:10.1080/1024533031000107514
- Koga M, Kusukawa J, Hayabuchi N. Spontaneous regression of extranodal malignant lymphoma occurred in the gingiva. Oral Oncol. 2003;39(3):323–324. doi:10.1016/s1368-8375(02)00122-7
- Kon T, Kakita A, Koide A, et al. A primary CNS lymphoma in spontaneous remission for 3.5 years after initial detection of the lesions by MRI. Brain Tumor Pathol. 2003;20:27–31. doi:10.1007/BF02478944
- Ogata M, Kikuchi H, Ono K, Ohtsuka E, Gamachi A, Kashima K, Nasu M. Spontaneous remission of Epstein-Barr virus-negative non-Hodgkin's lymphoma after withdrawal of cyclosporine in a patient with refractory anemia. Int J Hematol. 2004;79(2):161–164. doi:10.1532/ijh97.03095
- Heibel H, Knödgen R, Bredenfeld H, Wickenhauser C, Scheer M, Zöller JE. Complete spontaneous remission of an aggressive non-Hodgkin’s lymphoma with primary manifestation in the oral cavity. Leuk Lymphoma. 2004;45(1):171–174. doi:10.1080/1042819031000139747
- Iihara K, Yamaguchi K, Nishimura Y, Iwasaki T, Suzuki K, Hirabayashi Y. Spontaneous regression of malignant lymphoma of the breast. Pathol Int. 2004;54(7):537–542. doi:10.1111/j.1440-1827.2004.01652.x
- Chang YC, Chang CH, Liu YT, Tsai KB, Liu TC, Lin YN. Spontaneous regression of a large-cell lymphoma in the conjunctiva and orbit. Ophthal Plast Reconstr Surg. 2004;20(6):461–463. doi:10.1097/01.iop.0000144791.05993.64
- Kumar R, Bhargava P, Zhuang H, Yu JQ, Schuster SJ, Alavi A. Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging. Clin Nucl Med. 2004;29(11):685–688. doi:10.1097/00003072-200411000-00002
- Ugurlu S, Bartley GB. Evolution of an orbital apex tumor over a decade. Ophthal Plast Reconstr Surg. 2004;20(1):75-77. doi:10.1097/01.IOP.0000105740.40210.66
- Thonhofer R, Gaugg M, Kriessmayr M, Neumann HJ, Erlacher L. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment. Ann Rheum Dis. 2005;64(7):1098-1099. doi:10.1136/ard.2004.026252
- Futagami A, Aoki M, Kawana S. A case of peripheral T-cell lymphoma unspecified involving subcutaneous tissue. Leuk Lymphoma. 2005;46(5):785–788. doi:10.1080/10428190500051406
- Parekh S, Heberit T, Ratech H, Sparano J. Variable problems in lymphomas: Case 3. Spontaneous regression of HIV-associated Burkitt’s lymphoma of the cecum. J Clin Oncol. 2005;23(31):8116–8117. doi:10.1200/JCO.2005.08.079
- Kamiya T, Saga K, Yanagisawa K, Kaneko R, Yamashita T, Ishida O, Jimbow K. Small cell variant of CD30+ primary cutaneous T‐cell lymphoma with epidermotropism that completely regressed after incisional skin biopsy. Br J Dermatol. 2006;155(2):484–487. doi:10.1111/j.1365-2133.2006.07337.x
- Sakuma H, Okabe M, Yokoi M, Eimoto T, Inagaki H. Spontaneous regression of intraoral mucosa-associated lymphoid tissue lymphoma: molecular study of a case. Pathol Int. 2006;56(6):331-335. doi:10.1111/j.1440-1827.2006.01967.x
- Svensson AM, Jacobson ER, Ospina D, Tindle BH. Reversible Epstein-Barr virus-negative lymphadenopathy and bone marrow involved by Hodgkin’s lymphoma in a rheumatoid arthritis patient undergoing long-term treatment with low-dose methotrexate: a case report and review of the literature. Int J Hematol. 2006;83(1):47-50. doi:10.1532/IJH97.NA0503
- Partap S, Spence AM. Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man. J Neurooncol. 2006;80(3):305–307. doi:10.1007/s11060-006-9192-3
- Matsuo T, Ichimura K, Yoshino T. Spontaneous regression of bilateral conjunctival extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. J Clin Exp Hematop. 2007;47(2):79–81. doi:10.3960/jslrt.47.79
- Patel P, Godwin J, Velankar M, Alkan S. Nodal ALK positive anaplastic large cell lymphoma of the axilla with spontaneous regression. Leuk Lymphoma. 2007;48(6):1250–1252. doi:10.1080/10428190701342026
- Shimada K, Matsui T, Kawakami M, Nakayama H, Ozawa Y, Mitomi H, Tohma S. Methotrexate‐related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritis. Scand J Rheumatol. 2007;36(1):64-67. doi:10.1080/03009740600902403
- Armstrong R, Bradrick J, Liu YC. Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: a case report. J Oral Maxillofac Surg. 2007;65(7):1361–1364. doi:10.1016/j.joms.2005.12.039
- Abe R, Ogawa K, Maruyama Y, Nakamura N, Abe M. Spontaneous regression of diffuse large B-cell lymphoma harbouring Epstein-Barr virus: a case report and review of the literature. J Clin Exp Hematop. 2007;47(1):23–26. doi:10.3960/jslright.47.23
- Rujirojindakul P, Kayasut K, Rohitoprakarn M, Lekhakula A. A unique case of transient spontaneous regression complicated with tumor lysis syndrome of T-cell lymphoblastic lymphoma in HIV-infected patient without antiretroviral therapy. J Med Assoc Thai. 2007;90(9):1930-1933.
- Mohsin N, Budruddin M, Kamble P, Khalil M, Pakkyarra A, Jha A, Mohammed E, Ahmed H, Ahmed J, Thomas S, Campistol JM, Daar A. Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus. Transplant Proc. 2007;39(4):1267–1271. doi:10.1016/j.transproceed.2007.03.092
- Daly RM, Healy CM, Toner ME, Flint SR. Spontaneous regression of non-Hodgkin's lymphoma in the oral cavity after incisional biopsy. Br J Oral Maxillofac Surg. 2008;46(3):223–225. doi:10.1016/j.bjoms.2007.03.010
- McCabe MG, Hook CE, Burke GA. Spontaneous regression of an EBV-associated monoclonal large B-cell proliferation in the mastoid of a young child following surgical biopsy. Pediatr Blood Cancer. 2008;51(4):557–559. doi:10.1002/pbc.21637
- Isobe Y, Aritaka N, Sasaki M, Oshimi K, Sugimoto K. Spontaneous regression of natural killer cell lymphoma. J Clin Pathol. 2009;62(7):647–650. doi:10.1136/jcp.2008.062976
- Chiu LS, Choi PCL, Luk NM, Chang M, Tang WY. Spontaneous regression of primary cutaneous Epstein–Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient. Clin Exp Dermatol. 2009;34:e21–e24. doi:10.1111/j.1365-2230.2008.03145.x
- Engel PA, Lee C. Sudden appearance and spontaneous regression of diffuse large B cell lymphoma in a man with a broken arm. BMJ Case Rep. 2009;2009:bcr10.2008.1036. doi:10.1136/bcr.10.2008.1036
- Makino Y, Suzuki H, Nishizawa T, Kameyama K, Hisamatsu T, Imaeda H, Mukai M, Hibi T. Ileal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with a Large-Cell Component That Regressed Spontaneously. Gut Liver. 2010;4(1):117–121. doi:10.5009/gnl.2010.4.1.117
- Rampisela D, Donner LR. An unusual self-limited clonal Mott cell proliferation with lymphoplasmacytic lymphoma-like features in a child with the Wiskott-Aldrich syndrome and von Recklinghausen’s neurofibromatosis. Pathol Res Pract. 2010;206(7):467-471. doi:10.1016/j.prp.2009.07.003
- Iwatani T, Kawabata H, Miura D, Ota Y, Ohashi K. Complete spontaneous regression of primary diffuse large B-cell lymphoma of the breast. J Clin Oncol. 2011;29(5):e113-e115. doi:10.1200/JCO.2010.31.2801
- Norimura D, Isomoto H, Imaizumi Y, Akazawa Y, Matsushima K, Inoue N, Yamaguchi N, Ohnita K, Shikuwa S, Arima T, Hayashi T, Takeshima F, Miyazaki Y, Nakao K. Case series of duodenal follicular lymphoma, observed by magnified endoscopy with narrow-band imaging. Gastrointest Endosc. 2011;74(2):428–434. doi:10.1016/j.gie.2011.03.1237
- Gencoglan G, Ozturk F, Inanir I, Miskioglu M, Temiz P, Gunduz K. Primary cutaneous anaplastic CD30+ large-cell lymphoma that completely regressed after incisional skin biopsy. Cutan Ocul Toxicol. 2011;30(2):163–166. doi:10.3109/15569527.2010.534749
- Cassaday RD, Malik JT, Chang JE. Regression of Hodgkin lymphoma after discontinuation of a tumor necrosis factor inhibitor for Crohn's disease: a case report and review of the literature. Clin Lymphoma Myeloma Leuk. 2011;11(3):289–292. doi:10.1016/j.clml.2011.03.018
- Kameda G, Kempf W, Oschlies I, Michael K, Seifert G, Längler A. Nodal anaplastic large-cell lymphoma ALK-1− with CD30+ cutaneous lymphoproliferation treated with mistletoe: spontaneous remission or treatment response? Klin Padiatr. 2011;223(6):364–367. doi:10.1055/s-0031-1285914
- Kase S, Namba K, Jin XH, Kubota KC, Ishida S. Spontaneous regression of intraocular lymphoma. Ophthalmology. 2012;119(5):1083–1084. doi:10.1016/j.ophtha.2011.12.011
- Buckner TW, Dunphy C, Fedoriw YD, van Deventer HW, Foster MC, Richards KL, Park SI. Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections. Clin Lymphoma Myeloma Leuk. 2012;12(6):455–458. doi:10.1016/j.clml.2012.06.007
- Mohsen A, Ghanem H, El-Bayoumi J, Tabbara I. Spontaneous regression of classical Hodgkin lymphoma: a case report and review of the literature. Clin Adv Hematol Oncol. 2012;10(11):762–764.
- Biswas A, Tan BB. Spontaneous regression of a childhood tumour with anaplastic histological features. Clin Exp Dermatol. 2013;38(3):318–320. doi:10.1111/j.1365-2230.2012.04427.x
- Zhang YX, Ding MP, Zhang T, Tang YL, Guo Y, Fan J, Chen LR, Chen Q. Lymphomatoid granulomatosis with CNS involvement can lead to spontaneous remission: case study. CNS Neurosci Ther. 2013;19(7):536–538. doi:10.1111/cns.12109
- Udupa K, Philip A, Rajendranath R, Sagar T, Majhi U. Spontaneous regression of primary progressive Hodgkin's lymphoma in a pediatric patient: a case report and review of literature. Hematol Oncol Stem Cell Ther. 2013;6(3-4):112–116. doi:10.1016/j.hemonc.2013.06.004
- Mizuno T, Ishigaki M, Nakajima K, Matsue T, Fukushima M, Minato H, et al. Spontaneous remission of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly. Case Rep Oncol. 2013;6(2):269–274. doi:10.1159/000345572
- Humeniuk MS, Liang JJ, Howard M, Inwards DJ. Spontaneous complete remission of angioimmunoblastic T-cell lymphoma. Proc (Bayl Univ Med Cent). 2014;27(3):242–245. doi:10.1080/08998280.2014.11929126
- Sekiguchi Y, Shimada A, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Komatsu N, Noguchi M. Spontaneous regression of a clinically-advanced histologically low-grade follicular lymphoma involving the breast: case report and review of the literature. Indian J Hematol Blood Transfus. 2014;30(Suppl 1):320–324. doi:10.1007/s12288-014-0382-4
- Rojas-Hernandez CM, Coleman JF, Czuchlewski DR, Fekrazad MH. Spontaneous regression of high grade primary gastric lymphoma in an untreated viral hepatitis infection. Leuk Lymphoma. 2014;55(11):2643–2645. doi:10.3109/10428194.2014.887710
- Kang HS, Lee HY, Kim SJ, Kim SC, Kim YK, Park GS, Lee KY, Jung JI, Kang JY. An unusual presentation of pulmonary mucosa-associated lymphoid tissue lymphoma as diffuse pulmonary infiltrates with spontaneous regression. Cancer Res Treat. 2015;47(4):943–948. doi:10.4143/crt.2014.016
- Kaibuchi N, Okamoto T, Kataoka T, Kumasaka A, Ando T. A case of spontaneous regression of lymphoma in the mandibular gingiva after biopsy. Oral Maxillofac Surg Cases. 2015;1(3):33–37. doi:10.1016/j.omsc.2015.06.002
- Birendra KC, Afzal MZ, Wentland KA, Hashmi H, Singh S, Ivan E, Lakhani N. Spontaneous regression of refractory diffuse large B-cell lymphoma with improvement in immune status with ART in a patient with HIV: a case report and literature review. Am J Case Rep. 2015;16:347–352. doi:10.12659/AJCR.892883
- Bekoz HS, Kantarcioglu B, Tecimer T, Sargin D. Spontaneous regression of a systemic ALK (+) anaplastic large cell lymphoma carrying ALK gene rearrangement that developed after PPD tuberculin skin test. Leuk Lymphoma. 2016;57(2):480–482. doi:10.3109/10428194.2015.1058935
- Igawa T, Sato Y, Kawai H, Kondo E, Takeuchi M, Miyata-Takata T, Takata K, Yoshino T. Spontaneous regression of plasmablastic lymphoma in an elderly human immunodeficiency virus (HIV)-negative patient. Diagn Pathol. 2015;10:183. doi:10.1186/s13000-015-0421-y
- Takahashi T, Ikejiri F, Takami S, Okada T, Kumanomidou S, Adachi K, et al. Spontaneous regression of intravascular large B-cell lymphoma and apoptosis of lymphoma cells: a case report. J Clin Exp Hematop. 2015;55(3):151–156. doi:10.3960/jslrt.55.151
- Kato M, Uemura Y, Sato K, Tsuruoka Y, Yokoi S, Nishio Y, et al. Spontaneous remission in a patient with follicular lymphoma carrying T cell-rich neoplastic follicles and a new complex variant translocation of t(14;18): t(5;14;18)(p15;q32;q21.3). Leuk Lymphoma. 2015;56(7):2187–2189. doi:10.3109/10428194.2014.987767
- Ureshino H, Miyahara M. Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia. Ann Hematol. 2016;95(5):841–843. doi:10.1007/s00277-016-2624-z
- Ayala D, Ramón MD, Cabezas M, Jordá E. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma with expression of follicular T-helper cell markers and spontaneous remission. Actas Dermosifiliogr. 2016;107(4):357–359. doi:10.1016/j.ad.2015.10.012
- Ogihara K, Kosaka T, Kikuchi E, Hongo H, Mikami S, Oya M. Spontaneous regression of Epstein-Barr virus-positive primary diffuse large B-cell lymphoma of the urinary bladder after the cessation of enzalutamide. Clin Genitourin Cancer. 2016;14(2):e215–e218. doi:10.1016/j.clgc.2015.12.028
- Sasaki J, Kurihara H, Nakano Y, Kotani K, Tame E, Sasaki A. Apparent spontaneous regression of malignant neoplasms after radiography: report of four cases. Int J Surg Case Rep. 2016;25:40–43. doi:10.1016/j.ijscr.2016.05.049
- Fukushima K, Hirosako S, Tenjin Y, Mukasa Y, Kojima K, Saeki S, Okamoto S, Ichiyasu H, Fujii K, Kikukawa Y, Kawanaka K, Kohrogi H. Pulmonary mucosa-associated lymphoid tissue lymphoma with spontaneous regression after computed tomography-guided needle biopsy: a case report and summary of 8 reported cases. Intern Med. 2016;55(24):3655–3660. doi:10.2169/internalmedicine.55.6874
- Potts DA, Fromm JR, Gopal AK, Cassaday RD. Spontaneous remission of an untreated, MYC and BCL2 coexpressing, high-grade B-cell lymphoma: a case report and literature review. Case Rep Hematol. 2017;2017:2676254. doi:10.1155/2017/2676254
- Hees H, Geißler EM, Wolter M, Lamos C, Löser CR, Dippel E. Pyogenic variant of primary cutaneous CD30+ anaplastic large-cell lymphoma: spontaneous remission in a young adult. J Dtsch Dermatol Ges. 2017;15(9):952–955. doi:10.1111/ddg.13315
- Cornish N, Maybury B, Otton S. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma. Br J Haematol. 2018;180(1):176. doi:10.1111/bjh.14959
- Chan AM, Huttner A, Baehring J. Disappearing leukoencephalopathy. Clin Neuroradiol. 2017;1–5. doi:10.1007/s00062-017-0650-4
- Jimura N, Fujii K, Baba A, Higashi Y, Kanekura T. Spontaneous regression of a primary cutaneous diffuse large B-cell lymphoma, leg type. J Dermatol. 2017;44(6):608–609. doi:10.1111/1346-8138.13496
- Fleming D, Stone J, Tansley P. Spontaneous regression and resolution of breast implant-associated anaplastic large cell lymphoma: implications for research, diagnosis and clinical management. Aesthetic Plast Surg. 2018;42(3):672–678. doi:10.1007/s00266-017-1064-z
- Ye H, Desai A, Gong T, Zeng D, Nomie K, Chen W, Wang W, Romaguera J, Wang ML. Spontaneous regression of mantle cell lymphoma: a report of four cases. Cancer Commun (Lond). 2018;38(1):30. doi:10.1186/s40880-018-0306-z
- Froehlich A, Schmidt S, Landsberg J, Bieber T, Wenzel J. Spontaneous Regression of Tumor-Stage Cutaneous T-Cell Lymphoma in a Multiple Sclerosis Patient After Discontinuing Fingolimod. Mult Scler. 2018;24(13):1785–1787. doi:10.1177/1352458518774444
- Graham PM, Richardson AS, Schapiro BL, Saunders MD, Stewart DM. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response. JAAD Case Rep. 2018;4(4):305–309. doi:10.1016/j.jdcr.2017.10.012
- Ramos R, Fernandes JS, Almeida M, Almeida R. A Rare Case of Spontaneous Remission and Relapse of a Primary Central Nervous System Lymphoma. Acta Med Port. 2018;31(12):777–783. doi:10.20344/amp.10198
- Toberer F, Mechtersheimer G, Jaschinski H, Enk A, Hakim-Meibodi L, Haenssle HA. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type. Acta Derm Venereol. 2018;98(6):608–609. doi:10.2340/00015555-2921
- Aiko N, Sekine A, Umeda S, et al. The Spontaneous Regression of Grade 3 Methotrexate-Related Lymphomatoid Granulomatosis: A Case Report and Literature Review. Intern Med. 2018;57(21):3163–3167. doi:10.2169/internalmedicine.0542-17
- Swoboda S, Technau-Hafsi K, May AM, Wolter M, Kern JS, Meiss F. Recurrent Ulceronecrotic Plaques and Nodules With Spontaneous Remission. J Dtsch Dermatol Ges. 2018;16(9):1155–1158. doi:10.1111/ddg.13626
- Pasvolsky O, Berger T, Bernstine H, Hayman L, Raanani P, Vidal L. Spontaneous Regression of Hodgkin Lymphoma: Case Report and Review of the Literature. Acta Haematol. 2019;141(1):14–18. doi:10.1159/000494422
- Snijder J, Mihyawi N, Frolov A, Ewton A, Rivero G. Spontaneous Remission in Diffuse Large Cell Lymphoma: A Case Report. J Med Case Rep. 2019;13(1):28. doi:10.1186/s13256-018-1937-z
- Tanaka Y, Ishihara M, Miyoshi H, Hashimoto A, Shinzato I, Ohshima K. Spontaneous Regression of Diffuse Large B-Cell Lymphoma in the Small Intestine With Multiple Lymphadenopathy. J Clin Exp Hematop. 2019;59(1):17–21. doi:10.3960/jslrt.18020
- Yordanova K, Stilgenbauer S, Bohle RM, et al. Spontaneous Regression of a Plasmablastic Lymphoma With MYC Rearrangement. Br J Haematol. 2019;186(6):e203–e207. doi:10.1111/bjh.16082
- Hosoda C, Ishiguro T, Takahashi N, Kamiishi N, Shimizu Y, Takayanagi N. Spontaneous Regression of Primary Endobronchial Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue. Respir Med Case Rep. 2019;27:100826. doi:10.1016/j.rmcr.2019.100826
- Morigi A, Casadei B, Argnani L, Cavo M, Zinzani PL. Spontaneous Remission of Follicular Lymphoma. Hematol Oncol. 2019;37(5):626–627. doi:10.1002/hon.2653
- Nakamoto R, Okuyama C, Oka S. Complete Spontaneous Regression of Hepatosplenic T-Cell Lymphoma After Surgical Biopsy. Clin Nucl Med. 2020;45(2):e88–e91. doi:10.1097/RLU.0000000000002782
- Tang X, Tang J, Liu W, Wang L. Primary Cutaneous Marginal Zone B-Cell Lymphoma With Unusual Manifestation and Spontaneous Regression. Indian J Dermatol Venereol Leprol. 2020;86(4):428–431. doi:10.4103/ijdvl.IJDVL_516_19
- Fleming D, Stone J, Tansley P. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management. Aesthet Plast Surg. 2020;44(4):1109–1115. doi:10.1007/s00266-020-01810-2
- Stanoszek LM, Smith LB, Grajewski K, Reneau JC, Wilcox R, Perry AM. Spontaneous Regression of High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements: Case Report and Literature Review. Clin Lymphoma Myeloma Leuk. 2021;21(2):e120–e125. doi:10.1016/j.clml.2020.09.006
- Furukawa Y, Ando J, Ando M, et al. Long-Term Spontaneous Regression of Stage IV Diffuse Large B-Cell Lymphoma. J Clin Exp Hematop. 2021;61(3):168–172. doi:10.3960/jslrt.21002
- Gambichler T, Boms S, Hessam S, et al. Primary Cutaneous Anaplastic Large-Cell Lymphoma With Marked Spontaneous Regression of Organ Manifestation After SARS-CoV-2 Vaccination. Br J Dermatol. 2021;185(6):1259–1262. doi:10.1111/bjd.20630
- Desana B, Balbo Mussetto A, Macera A, Mariani L, De Rosa G, Cirillo S. Rare case of uterine cervix lymphoma with spontaneous regression: case report. J Obstet Gynaecol Res. 2021;47(2):807-811. doi:10.1111/jog.14562
- Peeters M, Geusens J, Van der Cruyssen F, et al. Spontaneous Remission of an Infraorbital Follicular B-Cell Lymphoma: Case Report and Review of the Literature. Pathol Oncol Res. 2021;27:642433. doi:10.3389/pore.2021.642433
- Gong D, Aronow ME, Eliott D. Rapid, Spontaneous Resolution of Prominent Subretinal Infiltrate in Vitreoretinal Lymphoma. J Vitreoretin Dis. 2021;6(1):80–85. doi:10.1177/24741264211009804
- Sherkat R, Afshar Moghaddam N, Reisi N, Rezaei M. Spontaneous Regression of Diffuse Large B-Cell Lymphoma in a Patient With Ataxia-Telangiectasia. Adv Biomed Res. 2022;11:31. doi:10.4103/abr.abr_169_21
- Aoki Y, Hasegawa S, Miyabe S, Nagao T. Spontaneous Regression of Malignant Lymphoma of the Maxillary Gingiva Following Biopsy. Int J Oral Maxillofac Surg. 2022;51(9):1145–1148. doi:10.1016/j.ijom.2021.09.006
- Lee KT, Misron NA, Abdul Aziz N, Wong CH, Liew HK. Spontaneous Regression of Plasmablastic Lymphoma in an Immunocompetent Patient: Case Report and Review of the Literature. Case Rep Hematol. 2022;2022:1142049. doi:10.1155/2022/1142049
- Ogawa A, Nakagawa T, Kumaki Y, Hosoya T, Oda G, Mori M, Fujioka T, Kubota K, Onishi I, Uetake H. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature. J Med Case Rep. 2022;16(1):49. doi:10.1186/s13256-022-03274-1
- Kongwattananon W, Kumar A, Simard J, Wiley HE, Sen HN, Kodati S. Secondary Vitreoretinal Lymphoma With Spontaneous Regression. Am J Ophthalmol Case Rep. 2022;25:101357. doi:10.1016/j.ajoc.2022.101357
- Gan L, Ye J. Spontaneous Regression of Secondary Vitreoretinal Lymphoma After Diagnostic Vitrectomy: Case Report. BMC Ophthalmol. 2023;23(1):222. doi:10.1186/s12886-023-02967-5
- Hayashino K, Meguri Y, Yukawa R, et al. Spontaneous Regression of Dasatinib-Related Primary Effusion Lymphoma-Like Lymphoma. Int J Hematol. 2023;117(1):137–142. doi:10.1007/s12185-022-03449-y
- Li F, Wang L. Spontaneous Regression of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type After Biopsy. Indian J Dermatol Venereol Leprol. 2023;89(1):110–113. doi:10.25259/IJDVL_1055_19
- Aizawa K, Yamazaki F, Shima H, et al. A 15-Year-Old Boy with Primary Maxillary Bone Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma Relapsed with Rib Metastasis after Spontaneous Remission of a Maxillary Bone Lesion: A Case Report and Literature Review. Case Rep Oncol. 2023;16(1):308–314. doi:10.1159/000530459
- Abla D, Al-Battashi A, Albiroty K, Abu Qasida K, Al-Rahbi N, Al-Awaidy S. Spontaneous Remission of Angioimmunoblastic T-Cell Lymphoma in a Child With Ataxia-Telangiectasia: A Case Report. J Med Case Rep. 2023;17(1):347. doi:10.1186/s13256-023-04050-5
- Khaw ELY, Gan WF, Zaidan NZ. Spontaneous Regression of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in an HIV-Positive Patient: A Case Report and Literature Review. Cureus. 2024;16(3):e55790. doi:10.7759/cureus.55790
- Winkler M, Albrecht JD, Sauer C, et al. Spontaneous Regression of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: A Case Series and Review of the Literature. J Dermatol. 2024;51(9):1233–1239. doi:10.1111/1346-8138.17339
- Tomai RA, Iluta S, Tigu AB, et al. “Lazarus Response” When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy. Diagnostics (Basel). 2024;14(18):2084. doi:10.3390/diagnostics14182084
- Goto T, Hatano K, Kanemura N, Makita H, Goto H. Spontaneous Regression of Plasmablastic Lymphoma Associated With Methotrexate After Withdrawal. J Hematol. 2024;13(6):290–294. doi:10.14740/jh1361
- Teoh XY, Mashor Mansor M, Mohd Affandi A, Awang A, Faizah Baharom Z. Spontaneous Regression of Cutaneous T Cell Lymphoma in an HIV-Positive Patient. Leuk Lymphoma. 2025;66(4):794–796. doi:10.1080/10428194.2024.2433616
- Li S, Yu FH, Yanfen S. A Case of Spontaneous Remission of Non-Hodgkin's Lymphoma in the Lung. Clin Case Rep. 2025;
- Moreno, A., Curcó, N., Serrano, T., Garcia, J., Llistosella, E., & Bordas, X. (1991). Disseminated, miliarial type lymphocytoma cutis. A report of two cases. Acta dermato-venereologica, 71(4), 334–336. https://doi.org/10.2340/0001555571334336
- Weintraub LR. Lymphosarcoma: Remission Associated With Viral Hepatitis. JAMA. 1969;210(8):1590–1591. doi:10.1001/jama.1969.03160340198034
- Büchi, G., Termine, G., Zappalà, C., Girotto, M., Grosso, E., & Autino, R. (1983). spontaneous complete remission of CLL. report of a case studied with monoclonal antibodies. Acta haematologica, 70(3), 198–201. https://doi.org/10.1159/000206723
- Kwittken, J., & Goldberg, A. F. (1966). Follicular lymphoma of the skin. Archives of dermatology, 93(2), 177–183.
- Krikorian, J. G., Porightlock, C. S., Cooney, P., & Rosenberg, S. A. (1980). spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases. Cancer, 46(9), 2093–2099. https://doi.org/10.1002/1097-0142(19801101)46:9<2093::aid-cncr2820460931>3.0.co;2-4
- Stevanovic & Majcan, 1961. Cutaneous Lymphoblastoma: report of two Cases with Unusual Courses. D.V. Stevanović, D.D. Majcan; Cutaneous Lymphoblastoma: report of two Cases with Unusual Courses. Dermatologica 1 April 1964; 129 (4): 329–338. https://doi.org/10.1159/000254646
- Gürçay A. spontaneous, temporary regression in a lymphosarcoma: can procaine produce this effect?. Turk J Pediatr 1969; 11: 9-17.
- monthstanaro, A., & Patton, R. (1976). Primary splenic malignant lymphoma, histiocytic type, with sclerosis: report of a case with long-term survival. Cancer, 38(4), 1625–1628. https://doi.org/10.1002/1097-0142(197610)38:4<1625::aid-cncr2820380430>3.0.co;2-x
- Williams M. V. (1980). spontaneous regression of cutaneous Hodgkin's disease. British medical journal, 280(6218), 903. https://doi.org/10.1136/bmj.280.6218.903
- Green, J. A., Arnold, A. M., Macbeth, F. R., Mead, G. M., Williams, C. J., Wright, D. H., & Whitehouse, J. M. (1984). Late recurrence in Hodgkin's disease: a report of two cases. Medical and pediatric oncology, 12(2), 148–149. https://doi.org/10.1002/mpo.2950120218
- Hernández Rubio, L., Giner Bernabeu, J. C., Perez Sempere, Á., & Toro, P. (2013). Primary cerebral lymphoma with spontaneous remission. Neurologia (Barcelona, Spain), 28(2), 123–126. https://doi.org/10.1016/j.nrl.2011.08.002
- Alcántara-González, J., González-García, C., Fernández-Guarino, M., & Jaén-Olasolo, P. (2014). spontaneous regression of primary diffuse large B-cell lymphoma, leg type. Actas dermo-sifiliograficas, 105(1), 78–83. https://doi.org/10.1016/j.ad.2012.07.009
- González Fernández, D., Valdés Pineda, F., Gómez Díez, S., & Vivanco Allende, B. (2015). Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoma With spontaneous Regression After Biopsy. Actas dermo-sifiliograficas, 106(9), 767–768. https://doi.org/10.1016/j.ad.2015.02.015
- Marrero-Alemán, G., monthstenegro-Dámaso, T., & Peñate, Y. (2017). Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With spontaneous Regression After Biopsy. The American Journal of dermatopathology, 39(10), 785–787. https://doi.org/10.1097/DAD.0000000000000874
- monthszen, Y., Nakahara, M., & Nishisaka, T. (2013). spontaneous regression of primary malignant lymphoma of the prostate. Case reports in urology, 2013, 363072. https://doi.org/10.1155/2013/363072
- Adiguzel, C., Bozkuright, S. U., Kaygusuz, I., Uzay, A., Tecimer, T., & Bayik, M. (2009). Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature. Apmis : acta pathologica, microbiologica, et immunologica Scandinavica, 117(3), 222–229. https://doi.org/10.1111/j.1600-0463.2008.00005.x
- Blokx, W. A., Andriessen, M. P., van Hamersvelt, H. W., & van Krieken, J. H. (2002). Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease. The American Journal of dermatopathology, 24(5), 414–422. https://doi.org/10.1097/00000372-200210000-00008
- Körner, S., Raab, P., Brandis, A., & Weissenborn, K. (2011). spontaneous regression of an intracerebral lymphoma (ghost tumor) in a liver-engrafted patient. The neurologist, 17(4), 218–221. https://doi.org/10.1097/NRL.0b013e318220c666
- Lelièvre, J. D., Sacre, K., Adle-Biassette, H., Molinier-Frenkel, V., Gaulard, P., & Papo, T. (2005). Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression. Journal of the American Academy of Dermatology, 52(2 Suppl 1), 24–27. https://doi.org/10.1016/j.jaad.2004.06.043
- Parekh, S. and Koduri, P.R. (2003), spontaneous regression of HIV-associated Hodgkin's disease. Am. J. Hematol., 72: 153-154. https://doi.org/10.1002/ajh.10289
- Tamás, L., Sári, E., Répássy, G. et al. spontaneous Remission in Localized Diffuse Large B-cell Lymphoma. Pathol. Oncol. Res. 17, 779–784 (2011). https://doi.org/10.1007/s12253-011-9379-6
- Nishimura, K., Oyama, N., Sekine, S., Shimizu, C., & Hasegawa, M. (2021). Spontaneous regression of long-standing bilateral nevoid hyperkeratosis of the nipple and areola in a young female: A case report. The Journal of dermatology, 48(4), e188–e189. https://doi.org/10.1111/1346-8138.15796
- Takatsu, H., Komatsu, T., Fukasawa, N., Fukuda, T., & Iguchi, Y. (2021). Spontaneously changing MRI findings of primary central nervous system vasculitis: A case report. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 83, 125–127. https://doi.org/10.1016/j.jocn.2020.11.012
- Han & Sokal, 1971. Spontaneous Remission of Leukemic Lymphoproliferative Disease. Cancer 27(3): March 1971; 586-595
- Getzen, J. H. 1967. Circulating Anticoagulant Due to Factor VIII Deficiency With Spontaneous Remission; Case Report. Southern Medical Journal 60(4): Apr 1967; 378-381
- Houbouyan et al., 1984. Lupus Anticoagulant and Acquired Prothrombin Deficiency During Viral Disease in a Child; Spontaneous Recovery. Archives Francaises de Pediatrie 41(6): Jun-Jul 1984; 417-420
- Ziliotto & Miotto, 1980. Angio-immunoblastic Lymphadenopathy with Spontaneous Remission in an Over 80-Year-Old Female Patient. Giornale di Gerontologia 28(8): 1980; (Recd 1981) 541-552
- Fiorillo et al., 1981. Angio-immunoblastic Lymphadenopathy with Dysproteinemia; Report of the First Case in Childhood Evolving Toward Spontaneous Remission. Cancer 48(7): Oct 1 1981; 1611-1614
- Matthews et al., 1988. A Case of Angio-immunoblastic Lymphadenopathy Associated with a Long Spontaneous Remission, Retrobulbar Neuritis, A Clonal Rearrangement of theT-Cell Receptor Gamma Chain Gene and an Unusual Marrow Infiltration. European Journal of Haematology 41(3): Sep 1988; 295-301